Eastern European countries that opted for less expensive (and possibly less safe and effective) AstraZeneca vaccine see surge in cases as supplies lag

Credit: Sky News
Credit: Sky News

Bulgaria, Croatia, Estonia, Latvia and Slovakia, which declined part of their Pfizer allotments to wait for Astra doses, are among the slowest in the bloc to administer vaccines, according to a European Union document seen by Bloomberg. While Pfizer has met its commitments, Astra has delivered just 30 million of its originally committed 120 million doses in the first quarter.

As a result, Bulgaria and Croatia are expected to vaccinate 45% of their populations by the middle of the year, according to the document, the lowest in the EU after the Czech Republic. Estonia will vaccinate 50%, Latvia 53% and Slovakia 46%. That compares to 61% in Germany, 80% in Denmark and 93% in Malta.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

So far, the EU has administered 15.5 doses per 100 people, less than a third of what the U.K. has managed. The U.S. has given 45 shots per 100 people.

The EU is discussing a mechanism to divert a batch of 10 million Pfizer doses that will be delivered earlier than expected to some of those countries in need. The latest proposal would see five of those countries — Bulgaria, Croatia, Estonia, Latvia and Slovakia — share 3 million of the extra shots, according to two people familiar with the talks.

Read the original post

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
ChatGPT-Image-Sep-21-2026-11_54_00-AM
Viewpoint: Activist environmental NGOs are turning from public funding to activist billionaires to support their campaigns. It won’t end well.
Screenshot 2026-08-12 at 1.22
Activists vs. Scientists: Could “Butterfly Effect” fears derail gene-drive research targeting the flesh-eating screwworm?
Screenshot-2026-09-16-at-10.27.33-AM
Viewpoint: SCOTUS poised to address First Amendment tension between mandatory vaccines, children’s health and religious freedom 
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
ChatGPT-Image-Sep-2-2026-02_03_32-PM
How much of a problem is AI’s water use?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.